Revelation Biosciences, Inc.
Revelation Biosciences, Inc. (REVB) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · REVB · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Revelation Biosciences, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
REVB insider buying and selling by quarter
REVB insider selling · REVB insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · REVB ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
REVB executive sell shares · REVB board member insider trading · REVB insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Apr 30, 2026 | Rolke James CEO · Director | Other | 10,115 | $11K | Form 4 |
| Apr 30, 2026 | Zygmont Chester Stanley III CFO | Other | 13,285 | $15K | Form 4 |
| Feb 3, 2026 | ROPER JESS Director | Other | 1,591 | $3K | Form 4 |
| Feb 3, 2026 | Chawla Lakhmir S Director | Other | 2,261 | $4K | Form 4 |
| Feb 3, 2026 | CARVER JENNIFER Director | Other | 1,661 | $3K | Form 4 |
| Feb 3, 2026 | Rolke James CEO · Director | Other | 8,521 | $16K | Form 4 |
| Feb 4, 2026 | Zygmont Chester Stanley III CFO | Other | 13,100 | $22K | Form 4 |
| Jan 8, 2026 | Rolke James CEO · Director | Award | 532,829 | $480K | Form 4 |
| Jan 8, 2026 | Zygmont Chester Stanley III CFO | Award | 78,145 | $70K | Form 4 |
| Jan 8, 2026 | CARVER JENNIFER Director | Award | 41,981 | $38K | Form 4 |
| Jan 8, 2026 | ROPER JESS Director | Award | 41,981 | $38K | Form 4 |
| Jan 8, 2026 | Chawla Lakhmir S Director | Award | 41,981 | $38K | Form 4 |
| Oct 29, 2025 | Chawla Lakhmir S Director | Award | 15,625 | $20K | Form 4 |
| Oct 29, 2025 | Rolke James CEO · Director | Award | 390,614 | $500K | Form 4 |
| Oct 29, 2025 | CARVER JENNIFER Director | Award | 15,625 | $20K | Form 4 |
| Oct 29, 2025 | Zygmont Chester Stanley III CFO | Award | 390,614 | $500K | Form 4 |
| Oct 29, 2025 | ROPER JESS Director | Award | 15,625 | $20K | Form 4 |
| Feb 11, 2025 | Chawla Lakhmir S Director | Award | 181 | $700 | Form 4 |
| Feb 11, 2025 | CARVER JENNIFER Director | Award | 181 | $700 | Form 4 |
| Feb 11, 2025 | ROPER JESS Director | Award | 181 | $700 | Form 4 |
| Feb 11, 2025 | Rolke James CEO · Director | Award | 30,095 | $116K | Form 4 |
| Feb 11, 2025 | Zygmont Chester Stanley III CFO | Award | 15,048 | $58K | Form 4 |
| Feb 11, 2025 | TIDMARSH GEORGE F Director | Award | 181 | $700 | Form 4 |
| Dec 8, 2023 | TIDMARSH GEORGE F Director | Sale | 27,771 | $14K | Form 4 |
| Oct 16, 2023 | TIDMARSH GEORGE F Director | Sale | 1,845 | $1K | Form 4 |
Zygmont Chester Stanley III
CFO
Date
Oct 29
Shares
390,614
Price
$1.28
Value
$500K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About REVB insider trading
REVB insider trades
Revelation Biosciences, Inc. (REVB) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Rolke James (CEO · Director), Zygmont Chester Stanley III (CFO), ROPER JESS (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. REVB insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Revelation Biosciences, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
REVB insider trading · 5 questionsThe insiders of Revelation Biosciences, Inc. (REVB) include executives and directors such as Rolke James (CEO · Director), Zygmont Chester Stanley III (CFO), ROPER JESS (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026